Prescribed medication availability and deliberate self-poisoning: A longitudinal study

Journal of Clinical Psychiatry

Volumn 73, Issue 4, 2012, Pages

  Gjelsvik, Bergljot ^a   Heyerdahl, Fridtjof ^b   Hawton, Keith ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; CARISOPRODOL; CONTRACEPTIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; PRESCRIPTION DRUG; PSYCHOTROPIC AGENT; SEDATIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HOSPITAL ADMISSION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; SELF MEDICATION; SELF POISONING;

EID: 84860557329     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07209     Document Type: Article

References (28)

1. Hawton K. Restricting access to methods of suicide - rationale and evaluation of this approach to suicide prevention. Crisis. 2007; 28(suppl 1):4-9. doi:10.1027/027-5910.28.S1.4
2. Prescott K, Stratton R, Freyer A, et al. Detailed analyses of self-poisoning episodes presenting to a large regional teaching hospital in the UK. Br J Clin Pharmacol. 2009;68(2):260-268. doi:10.1/j.1365-2125.209.03458.x PubMed
3. Hawton K, Townsend E, Deeks J, et al. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ. 2001;322(7296):1203-1207. doi:10.136/bmj.32.7296.1203 PubMed (Pubitemid 32453064)
4. Kalmar S, Szanto K, Rihmer Z, et al. Antidepressant prescription and suicide rates: effect of age and gender. Suicide Life Threat Behav. 2008; 38(4):363-374. doi:10.1521/suli.208.38.4.363 PubMed
5. Bergen H, Murphy E, Cooper J, et al. A comparative study of non-fatal self-poisoning with antidepressants relative to prescribing in three centres in England. J Affect Disord. 2010;123(1-3):95-101. doi:10.1016/j.jad.209.10.04 PubMed
6. Gunnell D, Hawton K, Murray V, et al. Use of paracetamol for suicide and non-fatal poisoning in the UK and France: are restrictions on availability justified? J Epidemiol Community Health. 1997;51(2):175-179. doi:10.136/jech.51.2.175 PubMed (Pubitemid 27229234)
7. Bergen H, Hawton K, Murphy E, et al. Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds. Br J Clin Pharmacol. 2009; 68(4):618-629. doi:10.1/j.1365-2125.209.03481.x PubMed
8. Høiseth G, Karinen R, Sørlid HK, et al. The effect of scheduling and withdrawal of carisoprodol on prevalence of intoxications with the drug. Basic Clin Pharmacol Toxicol. 2009;105(5):345-349. doi:10.1/j.1742-7843.209.0459.x PubMed
9. Ekeberg O, Jacobsen D, Flaaten B, et al. Effect of regulatory withdrawal of drugs and prescription recommendations on the pattern of self-poisonings in Oslo. Acta Med Scand. 1987;221(5):483-487. doi:10.1/j.0954-6820.1987.tb01284.x PubMed (Pubitemid 17099495)
10. Simkin S, Hawton K, Sutton L, et al. Co-proxamol and suicide: preventing the continuing toll of overdose deaths. QJM. 2005; 98(3):159-170. doi:10.1093/qjmed/hci026 PubMed (Pubitemid 40361313)
11. Hawton K, Bergen H, Simkin S, et al. Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: time series analysis. BMJ. 2009;338:b2270. doi:10.136/bmj.b270 PubMed
12. Nakagawa A, Grunebaum MF, Ellis SP, et al. Association of suicide and antidepressant prescription rates in Japan, 1999-2003. J Clin Psychiatry. 2007;68(6):908-916. doi:10.408/JCP.v68n0613 PubMed (Pubitemid 47015491)
13. Tournier M, Grolleau A, Cougnard A, et al. Factors associated with choice of psychotropic drugs used for intentional drug overdose. Eur Arch Psychiatry Clin Neurosci. 2009;259(2):86-91. doi:10.107/s0406-08-0839-2 PubMed
14. Kapur N, Cooper J, King-Hele S, et al. The repetition of suicidal behavior: a multicenter cohort study. J Clin Psychiatry. 2006;67(10):1599-1609. doi:10.408/JCP.v67n1016 PubMed (Pubitemid 44787444)
15. Owens D, Horrocks J, House A. Fatal and non-fatal repetition of self-harm: systematic review. Br J Psychiatry. 2002;181(3):193-199. doi:10.192/bjp.181.3.193 PubMed (Pubitemid 34983525)
16. Cavanagh JTO, Carson AJ, Sharpe M, et al. Psychological autopsy studies of suicide: a systematic review. Psychol Med. 2003;33(3):395-405. doi:10.1017/S0329170206943 PubMed (Pubitemid 36442783)
17. Hawton K, Zahl D, Weatherall R. Suicide following deliberate self-harm: long-term follow-up of patients who presented to a general hospital. Br J Psychiatry. 2003;182(6):537-542. doi:10.192/bjp.182.6.537 PubMed (Pubitemid 36649201)
18. Haw C, Hawton K, Houston K, et al. Psychiatric and personality disorders in deliberate self-harm patients. Br J Psychiatry. 2001; 178(1):48-54. doi:10.192/bjp.178.1.48 PubMed (Pubitemid 32055645)
19. Suominen K, Henriksson M, Suokas J, et al. Mental disorders and comorbidity in attempted suicide. Acta Psychiatr Scand. 1996;94(4): 234-240. doi:10.1/j.160-047.196.tb0985.x PubMed (Pubitemid 26344630)
20. Bjornaas MA, Jacobsen D, Haldorsen T, et al. Mortality and causes of death after hospital-treated self-poisoning in Oslo: a 20-year follow-up. Clin Toxicol (Phila). 2009;47(2):116-123. doi:10.1080/156365070171981
21. Hawton K, Harriss L, Zahl D. Deaths from all causes in a long-term follow-up study of 11,583 deliberate self-harm patients. Psychol Med. 2006;36(3):397-405. doi:10.1017/S0329170506914 PubMed
22. De Leo D, Scocco P, Marietta P, et al. Physical illness and parasuicide: evidence from the European Parasuicide Study Interview Schedule (EPSIS/WHO-EURO). Int J Psychiatry Med. 1999;29(2):149-163. PubMed doi:10.2190/E87K-FG03-CHE-UJD3
23. Høiseth G, Bramness JG, Christophersen AS, et al. Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992-2003. Int J Legal Med. 2007;121(5):403-409. doi:10.107/s0414-06-0139-1 PubMed (Pubitemid 47300302)
24. Furlanetto LM, Mendlowicz MV, Romildo Bueno J. The validity of the Beck Depression Inventory-Short Form as a screening and diagnostic instrument for moderate and severe depression in medical inpatients. J Affect Disord. 2005;86(1):87-91. doi:10.1016/j.jad.204.12.01 PubMed (Pubitemid 40487964)
25. Suominen KH, Isometsä ET, Henriksson MM, et al. Suicide attempts and personality disorder. Acta Psychiatr Scand. 2000;102(2):118-125. doi:10.1034/j.160-047.20.1020218.x PubMed (Pubitemid 30490350)
26. Verkes RC. PJ. Pharmacotherapy of suicidal ideation and behaviour. In: Hawton K, van Heeringen K, eds. International Handbook of Suicide and Attempted Suicide. Chicester, England: Wiley; 2000:487-502. doi:10.102/9780470698976.ch27
27. Haw C, Houston K, Townsend E, et al. Deliberate self-harm patients with alcohol disorders: characteristics, treatment, and outcome. Crisis. 2001; 22(3):93-101. doi:10.1027/027-5910.2.3.93 PubMed
28. Deisenhammer EA, Ing CM, Strauss R, et al. The duration of the suicidal process: how much time is left for intervention between consideration and accomplishment of a suicide attempt? J Clin Psychiatry. 2009;70(1):19-24. doi:10.408/JCP.07m03904 PubMed